02 May 2008
GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
30 April 2008
FDA approves Advair 250/50 for reduction of exacerbations in patients with COPD
30 April 2008
GSK announces changes to Corporate Executive Team
29 April 2008
GlaxoSmithKline awards £300,000 to community health charities in recognition of their work
25 April 2008
GSK receives positive opinion for conditional approval of new oral breast cancer treatment, Tyverb (lapatinib)
23 April 2008
Results announcement for the first quarter 2008
22 April 2008
GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development
22 April 2008
GlaxoSmithKline reports further progress of oncology portfolio
Back to top

